我国科学家在糖尿病研究与治疗领域取得重大突破，成功开发出一种基于人工智能与基因编辑技术的新型个体化治疗方案。该方案通过分析患者的基因组数据与临床指标，精准识别糖尿病亚型并预测药物反应，显著提升了治疗效率与安全性。同时，研究团队利用CRISPR基因编辑技术修复了实验模型中导致胰岛素分泌缺陷的基因突变，为根治糖尿病提供了新路径。这一成果已发表于国际顶级期刊《自然·医学》，并进入多中心临床试验阶段，有望在未来五年内惠及全球数亿患者。
Chinese scientists have achieved a major breakthrough in diabetes research and treatment by developing a novel personalized therapy approach integrating artificial intelligence and gene editing technology. By analyzing patients’ genomic data and clinical indicators, the method accurately identifies diabetes subtypes and predicts drug responses, significantly improving treatment efficacy and safety. The research team also utilized CRISPR gene editing to correct gene mutations causing insulin secretion defects in experimental models, offering a potential cure for diabetes. This breakthrough, published in Nature Medicine, has entered multicenter clinical trials and is expected to benefit hundreds of millions of patients worldwide within five years.
原创文章，作者：admin，如若转载，请注明出处：https://ktez.cn/23615.html